Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

183

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R06AX27	DESLOR CHAPHA	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	323,802 L.L
R06AX27	DESLORATADINE ARROW	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	256,674 L.L
R06AX27	ORADUS	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	199,657 L.L
R06AX27	RINA	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Syrup	159,917 L.L
R06AX28	RUPATADINE BIOGARAN	G	Rupatadine - 10mg	10mg	Tablet	341,336 L.L
R06AX29	LABIXTEN	B	Bilastine - 20mg	20mg	Tablet	584,571 L.L
R06AX29	LABIXTEN	B	Bilastine - 2.5mg/ml	2.5mg/ml	Solution	463,626 L.L
R07AA	SURFACTANTE B RICHET	G	Pulmonary surfactant, bovine - 200mg/8ml	200mg/8ml	Suspension	26,568,472 L.L
R07AA	INFASURF	B	Calfactant - 210mg/6ml	35mg/ml	Injectable suspension	40,596,749 L.L
R07AA	INFASURF	B	Calfactant - 105mg/3ml	35mg/ml	Injectable suspension	23,344,161 L.L
R07AA01	SURVANTA	B	Colfosceril palmitate - 200mg/8ml	200mg/8ml	Suspension	36,957,499 L.L
S01AA09	TETRACYCLINE EYE OINTMENT	G	Tetracycline HCl - 1%	1%	Ointment	71,672 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
S01AA12	TOBRASTILL	G	Tobramycin - 0.3%	0.3%	Drops solution	258,018 L.L
S01AA12	TOBRIN	G	Tobramycin - 0.3%	0.3%	Drops	169,324 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Ointment	280,863 L.L
S01AA13	FUCITHALMIC VISCOUS	B	Fusidic acid - 10mg/g	1%	Drops	443,468 L.L
S01AA13	OPTIFUCIN VISCOUS	G	Fusidic acid - 1%	1%	Drops	208,296 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.3%	Drops solution	681,328 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.3%	Ointment	593,978 L.L
S01AA26	AZYTER	G	Azithromycin (dihydrate) - 15mg/g	15mg/g	Drops solution	412,560 L.L
S01AD09	VIRGAN	B	Ganciclovir - 1.5mg/g	1.5mg/g	Gel	804,962 L.L
S01AD09	GANVIR	G	Ganciclovir - 0.15%	0.15%	Gel	698,798 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
S01AE01	FLOXIGEN	G	Ofloxacin - 3mg/ml	3mg/ml	Drops solution	358,806 L.L
S01AE01	OPTIFLOX	G	Ofloxacin - 3mg/ml	3mg/ml	Drops suspension	143,791 L.L
S01AE01	FLOXEDOL	G	Ofloxacin - 3mg/ml	3mg/ml	Gel	339,992 L.L
S01AE02	NAFLOX	G	Norfloxacin - 3mg/ml	3mg/ml	Drops	370,901 L.L
S01AE03	CILOXAN	B	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops solution	348,055 L.L

...

183

...